Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study on the Potential Benefit of Neoadjuvant Therapy for Advanced Gastric Cancer Based on Organoid Drug Susceptibility Screening

NCT05442138 is registered in ClinicalTrials.gov with Henan Cancer Hospital as lead sponsor.

NCT NCT05442138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05442138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study on the Potential Benefit of Neoadjuvant Therapy for Advanced Gastric Cancer Based on Organoid Drug Susceptibility Screening
Lead sponsor
Henan Cancer Hospital
Phase
Observational
Overall status
Unknown status
Start date
August 31, 2022
Completion date
June 30, 2024
Enrollment
54 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

early gastric cancer, tumor organoids